posted
looks like this has almost doubled since June.
Good pick!
July 18th, 2005 People's Republic of China-based American Oriental Bioengineering, Inc. (AOB) with a "Strong Buy" investment rating, a six-month Target Price of $ 4.05, a 12-month Target Price of $ 4.50, and a risk rating of "High" over both time periods.
American Oriental Bioengineering is a manufacturer and distributor of herbal-based medicines, health supplements and soybean peptide products, all of which the company manufactures in China using organic raw materials. The company has been expanding its operations at a rapid pace over the past two years via selective acquisitions of other Chinese companies with complementary products or product distribution capabilities.
AOB is an investment banking client of Westminster Securities Corporation, which makes a market in the trading of AOB shares.
For further information or a copy of Westminster Securities Corporation's latest equity research report covering AOB please contact:
-------------------- The road is full of potholes, and the car has no pothole guard... Yet the sun still allures the moon to bid her farewell until the stars cry with pain because the potholes are rough.
IP: Logged |
posted
Thanks. this thing is still going. moved through the 2.50 mark. we'll see how their next earning report looks. could make it to that price target by the end of the year
IP: Logged |